Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Fanucci, , Alessio,
DOB: 12-SEP-1964 (Age: 61)
Gender: male
Address:
Incrocio Combi, 822
33015 Moggio Udinese (Italy)
ID: 4754-874768-3 (ECI)
Report
Date: 14-MAR-2016
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ambulatori
33011 Artegna (Italy)
Specimen
Collected: 14-MAR-2016

Chemistry

Test 14-MAR-2016 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4 - 6 %
Glucose [Mass/volume] in Blood 92.3 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.5 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.8 3.5 - 5 mmol/L
Chloride [Moles/volume] in Blood 107.8 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.8 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 128.2 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 109.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 70.9 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 35.3 L 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating suboptimal long-term glucose control and possible prediabetes or early diabetes. All other parameters, including renal function, electrolytes, and lipid profile, are within normal limits except for low HDL cholesterol, which is a cardiovascular risk factor. Recommend lifestyle modification and follow-up for glycemic and lipid control.